Log In
BCIQ
Print this Print this
 

VAL-0620 (formerly 4s3-001)

  Manage Alerts
Collapse Summary General Information
Company Valerion Therapeutics LLC
DescriptionFusion protein of Valerion's 3E10, an equilibrative nucleoside transporter 2 (ENT2)-dependent cell-penetrant antibody, linked to myotubularin 1 (MTM1)
Molecular Target Myotubularin 1 (MTM1)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat myotubular myopathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today